Benign Prostatic Hyperplasia is not Prostate Cancer, so Thermobalancing Therapy is the First-Line Treatment for BPH

Benign prostatic hyperplasia (BPH)  is a non-cancerous  condition of the prostate. Therefore, BPH doesn’t spread (metastasize) to other parts of the body and is not usually life-threatening. Therefore, Thermobalancing therapy should be administered to men in the first place, when the enlarge prostate is diagnosed. Why? Because, Dr Allen’s Device that enables Thermobalancing therapy is effective, safe and cost-effective.

By the age of 60, 50% of men will suffer lower urinary tract symptoms (LUTS). LUTS due to BPH affects 80% men by the age of 80. It should be mentioned that BPH doesn’t increase the risk of prostate cancer and it isn’t considered a health problem unless it causes symptoms. It should be underlined that Dr Allen’s Device doesn’t treat prostate cancer.

Dr Allen’s device relieves LUTS, such as frequent or urgent need to urinate; increased frequency of urination at night; difficulty with starting urination; weak urine stream, etc. A clinical trial confirmed that Dr Allen’s device reduces the size of enlarged prostate, which leads to the improvement of the urinary symptoms due to BPH.Please watch a video: https://youtu.be/Fr3oFP8p3ks.

Dr Simon Allen explains that Thermobalancing therapy is effective, as it tackles the cause of prostate enlargement. According to the Origin of Diseases, explained by Dr. Allen, all chronic internal diseases have the same root, the pathological activity of the capillaries. As a result of changes in small blood vessels, the focus of hypothermia becomes a continuous trigger in the affected prostate tissue, which gradually increases the pressure in it, which leads to an additional tissue formation, leading to BPH.

Dr. Allen shared his opinion about the results of a clinical trial of Thermobalancing therapy in men with BPH at various international conferences around the world: in Spain, China, Italy, the UK and other countries. Medical specialists from the USA and Canada, India and Iran, Egypt and Saudi Arabia, and many European countries  supported the idea of implementation of this treatment to the standard practice, as BPH drugs can lead to impotence, increased breast size and even diabetes.

Fine Treatment, delivers the device  to all countries across the world within a week, by using Royal Mail tracking service. Men can receive the device and use it at home. Furthermore, Fine Treatment is a UK Department for International Trade (DIT) registered supplier to international buyers:

https://trade.great.gov.uk/suppliers/08994517/fine-treatment-limited/

For over 10 years Dr. Allen’s Devices have been successfully used by thousands of customers in over 100 countries. Read more at: http://finetreatment.com

Media Contact
Company Name: Fine Treatment
Contact Person: Dr Simon Allen, MD, PhD, Director of Fine Treatment
Email: Send Email
Phone: +447958878300
Address:29 Rewley Road
City: Oxford
Country: United Kingdom
Website: http://finetreatment.com/